| Serial Number | 79280862 |
| Word Mark | OXY GENE |
| Filing Date | Wednesday, January 15, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 16, 2021 |
| Registration Number | 6557311 |
| Registration Date | Tuesday, November 16, 2021 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 31, 2021 |
| Goods and Services | Supply in the nature of custom manufacture of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing for others of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production in the nature of custom manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents |
| Description of Mark | The mark consists of the stylized wording "OXY". The "O" and "X" are in blue, and the "Y" is in blue and purple. Below this wording is the stylized wording "GENE". The "G" is in blue and purple, the "E" is in blue, purple, and orange, and the "N" and "E" are in orange. There is a stylized blue, purple, red, and orange incomplete, wavy circle to the left of the wording that extends towards the right. The color white represents background and is not claimed as a part of the mark. |
| Indication of Colors claimed | The color(s) purple, blue, orange, and red is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "GENE" |
| Goods and Services | Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 17, 2020 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 17, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HENOGEN |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | B-6041 Gosselies BE |
| Party Name | HENOGEN |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | B-6041 Gosselies BE |
| Party Name | HENOGEN |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | B-6041 Gosselies BE |
| Party Name | NOVASEP PROCESS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | F-54340 POMPEY FR |
| Event Date | Event Description |
| Thursday, March 12, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, April 1, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, March 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, March 21, 2020 | APPLICATION FILING RECEIPT MAILED |
| Friday, April 10, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, April 11, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, April 28, 2020 | REFUSAL PROCESSED BY MPU |
| Tuesday, April 28, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, May 15, 2020 | REFUSAL PROCESSED BY IB |
| Tuesday, July 14, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 14, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 14, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 20, 2020 | FINAL REFUSAL E-MAILED |
| Monday, July 20, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, October 26, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 26, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 26, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 20, 2020 | FINAL REFUSAL WRITTEN |
| Tuesday, January 19, 2021 | EX PARTE APPEAL-INSTITUTED |
| Tuesday, January 19, 2021 | EXPARTE APPEAL RECEIVED AT TTAB |
| Tuesday, January 19, 2021 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Tuesday, January 26, 2021 | SUSPENSION LETTER WRITTEN |
| Friday, March 5, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Saturday, April 3, 2021 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Tuesday, April 6, 2021 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Friday, April 9, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, January 19, 2021 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, January 26, 2021 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 26, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, May 10, 2021 | CHANGE OF OWNER RECEIVED FROM IB |
| Tuesday, May 25, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Friday, July 23, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, July 9, 2021 | ASSIGNED TO LIE |
| Tuesday, July 13, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 13, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 23, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, July 23, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sunday, July 25, 2021 | EXPARTE APPEAL TERMINATED |
| Friday, July 23, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 23, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 11, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 11, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 11, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, August 23, 2021 | ASSIGNED TO EXAMINER |
| Sunday, August 29, 2021 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 31, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 31, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 16, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 3, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, May 23, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, February 16, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, May 3, 2022 | FINAL DISPOSITION PROCESSED |
| Saturday, May 4, 2024 | NEW REPRESENTATIVE AT IB RECEIVED |